Find research studies recruiting

New treatments will only become available by testing them in people with Parkinson’s

Cure Parkinson’s funds and supports clinical trials which seek to slow, stop or reverse Parkinson’s. Find out about the trials which are recruiting now, as part of our International Linked Clinical Trials (iLCT) programme developed in partnership with Van Andel Institute (VAI).

Our Clinical Trials Recruiting

Clinical Trials Recruiting

There are other studies recruiting now. Taking part in research is vital because it enables earlier, more accurate diagnoses, better predictions of future disease progression and more insight into the biology of the condition.

The Anle138b Phase 1b Study

Anle138b is a promising drug that targets alpha-synuclein with the aim of alleviating neurodegenerative symptoms. This study is now recruiting people with Parkinson’s to participate.

Find out more about anle138b clinical trials

The Predict-PD Study

PREDICT-PD is a ground-breaking project using simple tests to identify people at high risk of Parkinson’s disease before the symptoms appear. If we can predict who is going to get Parkinson’s, we will soon have treatments for those in the early stages that could slow or prevent the condition progressing.

Find Out More

QMAP-PD

QMAP-PD is an ongoing study using advanced brain imaging techniques based at the Wellcome Centre for Human Neuroimaging, UCL. The aim of this work is to better understand the causes of variability between individuals with a common disorder called Parkinson’s disease

Find Out More

PD Frontline

If you are a person with Parkinson’s who is interested in being genotyped in order to determine whether you are a carrier of a mutation in genes that have been associated with an increased risk of Parkinson’s, for example the GBA gene and the LRRK2 gene, you may then be eligible to participate in certain research studies or clinical trials.

Find Out MOre

Online Survey: Lucerne University, Switzerland – Parkinson’s and Music Therapy

A transdisciplinary research team in Switzerland is investigating how music can help people with Parkinson’s manage symptoms related to their movement and mood. This could be to do with movement, such as when walking or exercising, or your feelings, such as getting yourself going, or making you feel happy. If you would like to take part, an online questionnaire that takes about 30 minutes is available by clicking the button below.

The music survey

Online Survey: Therapies for later-stage Parkinson’s

How much do you know about the treatments available for people with later-stage Parkinson’s? A new survey from the EPDA and UK-based company Britannia Pharmaceuticals is investigating what information people with Parkinson’s (PwPs) receive about therapies for the later stages of the condition, and about non-oral therapies. PwPs of all ages and Parkinson’s stages are invited to complete around 20 multiple-choice questions in an online questionnaire.

Later-stage Parkinson’s survey

Other research study websites which might be of interest:

Fox Trial Finder

Fox Trial Finder is a user-friendly online matching tool from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) which helps you find observational studies and clinical trials in your area. Find out more.

Fox Insight

Fox Insight is an online clinical study building a large, diverse cohort of people with Parkinson’s and age-matched control volunteers to provide the research community with critical insight into the lived experience, genetics and variability of Parkinson’s. Find out more.

The Hope List

Find out more.

ClinicalTrials.gov

ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. Find out more.

PDTrialTracker.Info

The goal of PDTrialTracker.info is to provide Parkinson’s patients, families, researchers, health care providers, and other interested members of the PD community with analysis of ongoing PD clinical trials and observational studies throughout the world in order to:

understand the types of trials underway and where they are in the pipeline,
highlight the most promising avenues of research (e.g., particular disease modifying therapies, symptomatic treatments)
uncover roadblocks in the trial process and ways to address them (e.g., improving recruitment methods, enhancing clinical trial best practices),
promote accurate and timely sharing of trial information for ongoing and completed trials (e.g., within ClinicalTrials.gov),
facilitate greater collaboration between Parkinson’s patients, families, researchers, and physicians to accelerate progress towards a cure.